Chief Scientific Officer and Laboratory Director · Fulgent Genetics, Inc. (FLGT)

Hanlin Gao

A named executive officer of Fulgent Genetics in every fiscal year CompBrief holds from FY2021 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$2,352,249

Salary $513,000Stock awards $1,539,000

FY2024: $1,981,978

4th of 4 named executive officers at Fulgent Genetics by FY2025 total.

4 named officers on file for Fulgent Genetics, FY2025

Hanlin Gao’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • FLGT’s disclosed peer group of 12 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Fulgent Genetics’s whole pay program stands against its peers

  • Fulgent Genetics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on FLGT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 31, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Hanlin Gao’s full pay file as a PDF — free

More than this page: up to 10 years of Hanlin’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Hanlin Gao compensation by year

Fulgent Genetics Summary Compensation Table · all 5 fiscal years held
In US dollars, as Fulgent Genetics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023FY2024FY2025
Salary$427,262$510,292$513,000$513,000$513,000
Bonus$200,000$0$0$0$0
Stock awards$269,570$3,115,000$769,500$1,282,500$1,539,000
Option awards$0$0$0$0$0
Non-equity incentive$0$109,816$201,481$173,599$278,636
Pension and deferred compensation$0$0$0$0$0
All other$3,275$10,500$6,221$12,879$21,613
Total$900,107$3,745,608$1,490,202$1,981,978$2,352,249

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Fulgent Genetics, Inc. DEF 14A filed March 31, 2026, accession 0001674930-26-000020, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Fulgent Genetics, Inc. filed document, accession 0001674930-26-000020. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2026.

$900K
$3.7M
$1.5M
$2.0M
$2.4M
FY21
FY22
FY23
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU131,497$3,454,426—

Per the Outstanding Equity Awards at Fiscal Year-End table in Fulgent Genetics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

7 Form 4 lines since the FY2025 proxy (filed March 31, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-10-26Tax withholding—1,645$20.22984,472
2026-09-02Sale—1,673$19.66986,117
2026-08-27Sale—939$19.91987,790
2026-07-26Tax withholding—1,645$19.67988,729
2026-06-02Sale—1,688$17.89990,374
2026-05-27Sale—945$17.60992,062
2026-04-26Tax withholding—1,645$16.31993,007

The 7 most recent of 7 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Fulgent Genetics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Ming HsiehChief Executive Officer$6,207,000
Jian XiePresident and Chief Operating Officer$2,807,658
Paul KimChief Financial Officer$2,773,352
Hanlin Gao · this pageChief Scientific Officer and Laboratory Director$2,352,249

The full Fulgent Genetics compensation record

free company brief

This page is one person within Fulgent Genetics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Fulgent Genetics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Fulgent Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Hanlin Gao's compensation dossier · One-time report. No refunds.